Nightingale Health Plc’s financial reporting and Annual General Meeting in financial year 2026–2027

About this update from Nightingale Health Oyj Class B

Nightingale Health Plc | Stock Exchange Release | May 27, 2026 at 16:45:00 EESTDuring financial year 1 July 2026 – 30 June 2027, Nightingale Health Plc will release its financial reports as follows:Financial Statements Release for 1 July 2025 – 30 June 2026 on Wednesday, 16 September 2026Annual Report for financial year 2025–2026 during week 40/2026Half-year Financial Report for 1 July – 31 December 2026 on Tuesday, 9 March 2027.Nightingale Health’s Annual General Meeting 2026 will be held on Thursday, 5 November 2026. The Board of Directors will convene the meeting at a later date.For further information, please contactTeemu Suna, CEOAbout Nightingale HealthChronic diseases cause around 75% of deaths globally and place a growing burden on healthcare systems. The way to address this is preventive healthcare, but until recently the tools to detect disease risks at population scale have not existed. Nightingale Health has built them. The Nightingale Health Check is a blood-based risk detection test that identifies risks for multiple chronic diseases, including cardiovascular disease, type 2 diabetes, kidney disease, and fatty liver disease, from a single blood sample. It is designed to be applied population-wide, so healthcare systems can identify the people who would benefit most from preventive action before disease develops.Nightingale Health's technology is validated in over 900 peer-reviewed scientific publications and is used in many of the world's leading health studies, including the UK Biobank. In Finland, the Nightingale Health Check is in nationwide healthcare use, and over 200,000 people have already received their results. Nightingale Health operates globally with a parent company in Finland and subsidiaries in countries such as Japan, the United States, Singapore, and the United Kingdom, and has customers in more than 34 countries across healthcare and medical research. The company's Series B shares are listed on the Main Market of Nasdaq Helsinki and on the OTCQX International market. Read more: https://nightingalehealth.com/Image Attachments

View stock analysis, news, and events for Nightingale Health Oyj Class B